Vistra Biotech Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 5 Year, 8 Months
- Last Filing with ROC 31 Mar 2022
- Revenue Growth 0.40%
- Profit Growth -20.17%
- Ebitda 84.19%
- Net Worth 44.24%
- Total Assets 17.88%
About Vistra Biotech Pharma
Vistra Biotech Pharma Private Limited (VBPPL) is a Private Limited Indian Non-Government Company incorporated in India on 27 June 2019 (Five years and eight months 0 days old ). Its registered office is in Kolkata, West Bengal, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Archana Singh and Pankaj Agarwal serve as directors at the Company.
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51397WB2019PTC232655
- Company No.
232655
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Jun 2019
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Who are the key members and board of directors at Vistra Biotech Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Archana Singh  | Managing Director | 27-Jun-2019 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Pankaj Agarwal | Director | 27-Jun-2019 | Current |
Financial Performance of Vistra Biotech Pharma.
Vistra Biotech Pharma Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 0.4% increase. The company also saw a substantial fall in profitability, with a 20.17% decrease in profit. The company's net worth Soared by an impressive increase of 44.24%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vistra Biotech Pharma?
Unlock access to Vistra Biotech Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Vistra Biotech Pharma?
Unlock and access historical data on people associated with Vistra Biotech Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vistra Biotech Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vistra Biotech Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.